Dr Faye Wolstenhulme
Irena Bibby
Mike Cole
Lydia Grixti
Dr Naomi McGregor
et al. | Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves' disease | 2024 |
|
Dr Heather Lambert
Shaun Hiu
Dr Malcolm Coulthard
Professor John Matthews
Dr Eva-Maria Holstein
et al. | The Infant KIdney Dialysis and Utrafiltration (I-KID) Study: A Stepped-Wedge Cluster-Randomized Study in Infants, Comparing Peritoneal Dialysis, Continuous Venovenous Hemofiltration, and Newcastle Infant Dialysis Ultrafiltration System, a Novel Infant Hemodialysis Device | 2023 |
|
Dr Emma Clark
Dr Holly Fisher
Jenn Walker
Ruth Wood
Professor Helen Hancock
et al. | Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial | 2023 |
|
Lumbini Azim
Paul Hindmarch
Georgiana Browne
Dr Thomas Chadwick
Emily Clare
et al. | Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study) | 2021 |
|
Dr Arthur Pratt
Dr Stefan Siebert
Mike Cole
Dr Deborah Stocken
Amy Cranston
et al. | Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial | 2021 |
|
Dr Emma Clark
Dr Miranda Patterson
Shriya Sharma
Dr Holly Fisher
Denise Howel
et al. | Prostate cancer androgen receptor splice variant 7 biomarker study - A multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol | 2019 |
|
